Skip to main content

Table 1 Characteristics of the study subjects with and without NAFLD

From: The usefulness of obesity and lipid-related indices to predict the presence of Non-alcoholic fatty liver disease

 

Female

Male

 

Non-NAFLD

NAFLD

P-value

Non-NAFLD

NAFLD

P-value

No of subjects

6362

478

 

5382

2029

 

Age, years

42.89 (8.72)

47.64 (8.29)

<0.001

43.71 (9.27)

44.11 (8.20)

<0.001

Weight, kg

51.86 (7.06)

63.17 (9.97)

<0.001

64.65 (8.34

74.30 (10.56)

<0.001

Height, cm

158.37 (5.38)

157.04 (5.28)

<0.001

170.89 (6.04)

170.62 (5.94)

0.084

BMI, kg/m2

20.67 (2.57)

25.58 (3.57)

<0.001

22.12 (2.42)

25.48 (3.02)

<0.001

WC, cm

70.80 (7.30)

83.27 (8.86)

<0.001

77.99 (6.77)

86.62 (7.37)

<0.001

WHtR

0.45 (0.05)

0.53 (0.06)

<0.001

0.46 (0.04)

0.51 (0.04)

<0.001

TyG index

7.68 (0.54)

8.35 (0.53)

<0.001

8.14 (0.55)

8.64 (0.54)

<0.001

TyG-BMI

159.09 (25.66)

213.85 (34.25)

<0.001

180.37 (26.19)

220.34 (31.27)

<0.001

TyG-WC

544.58 (76.07)

696.06 (91.31)

<0.001

635.94 (81.00)

748.77 (84.35)

<0.001

TyG-WHtR

3.44 (0.49)

4.44 (0.59)

<0.001

3.72 (0.48)

4.39 (0.48

<0.001

ALT, IU/L

13.00 (11.00-17.00)

19.00 (15.00-26.00)

<0.001

18.00 (14.00-23.00)

29.00 (22.00-41.00)

<0.001

AST, IU/L

16.00 (13.00-19.00)

18.00 (15.00-22.00)

<0.001

17.00 (14.00-21.00)

21.00 (17.00-26.00)

<0.001

ALT/AST ratio

0.86 (0.71-1.00)

1.12 (0.89-1.37)

<0.001

1.07 (0.87-1.31)

1.43 (1.17-1.76)

<0.001

GGT, IU/L

12.00 (9.00-14.00)

15.00 (12.00-20.00)

<0.001

17.00 (14.00-24.00)

24.00 (18.00-35.00)

<0.001

HDL-C, mmol/L

1.66 (0.38)

1.38 (0.34)

<0.001

1.35 (0.35)

1.14 (0.25)

<0.001

TC, mmol/L

5.05 (0.86)

5.56 (0.92)

<0.001

5.06 (0.84

5.41 (0.85

<0.001

TG, mmol/L

0.54 (0.40-0.77)

1.02 (0.73-1.38)

<0.001

0.80 (0.58-1.16)

1.32 (0.91-1.86)

<0.001

FPG, mmol/L

4.94 (4.72-5.22)

5.27 (5.00-5.55)

<0.001

5.22 (5.00-5.50)

5.44 (5.16-5.66)

<0.001

HbA1c, %

5.17 (0.32)

5.42 (0.33)

<0.001

5.13 (0.31)

5.27 (0.33)

<0.001

SBP, mmHg

108.42 (13.77)

120.71 (16.04)

<0.001

116.04 (13.16)

124.04 (14.46)

<0.001

DBP, mmHg

67.00 (9.48)

75.11 (10.22) 74.50

<0.001

72.88 (9.32)

78.44 (10.08)

<0.001

TG/HDL-C

0.33 (0.22-0.50)

0.75 (0.50-1.11)

<0.001

0.61 (0.40-0.98)

1.19 (0.76-1.82)

<0.001

HSI

29.80 (3.58)

36.74 (4.76)

<0.001

31.05 (4.16)

37.43 (5.12)

<0.001

VAI

0.57 (0.39-0.88)

1.37 (0.89-2.05)

<0.001

0.74 (0.47-1.21)

1.49 (0.95-2.31)

<0.001

LAP

6.15 (3.27-11.14)

23.34 (15.09-36.34)

<0.001

9.92 (5.29-17.72)

27.81 (17.07-42.42)

<0.001

ABSI

0.07 (0.07-0.08)

0.08 (0.07-0.08)

<0.001

0.08 (0.07-0.08)

0.08 (0.07-0.08)

<0.001

BRI

2.33 (1.88-2.92)

3.82 (3.21-4.61)

<0.001

2.56 (2.12-3.04)

3.42 (2.98-3.97)

<0.001

COI

1.14 (0.07)

1.21 (0.07)

<0.001

1.16 (0.06)

1.21 (0.05)

<0.001

Habit of exercise

  

0.335

  

<0.001

 No

5351 (84.11%)

410 (85.77%)

 

4300 (79.90%)

1720 (84.77%)

 

 Yes

1011 (15.89%)

68 (14.23%)

 

1082 (20.10%)

309 (15.23%)

 

Drinking status

  

0.004

  

<0.001

 no or little

5986 (94.09%)

465 (97.28%)

 

3731 (69.32%)

1623 (79.99%)

 

 light

376 (5.91%)

13 (2.72%)

 

1096 (20.36%)

273 (13.45%)

 

 moderate

0 (0%)

0 (0%)

 

555 (10.31%)

133 (6.55%)

 

Smoking status

  

0.664

  

0.067

 Non

5609 (88.16%)

427 (89.33%)

 

1952 (36.27%)

758 (37.36%)

 

 Former

382 (6.00%)

24 (5.02%)

 

1538 (28.58%)

615 (30.31%)

 

 Current

371 (5.83%)

27 (5.65%)

 

1892 (35.15%)

656 (32.33%)

 
  1. Values were expressed as mean (SD) or medians (quartile interval) or n (%). Abbreviations: NAFLD: Nonalcoholic fatty liver disease; BMI: body mass index; WC: Waist circumference; WHtR: waist-to-height ratio; TyG index: triglyceride-glucose index; TyG-BMI: triglyceride glucose-body mass index; TyG-WC: triglyceride glucose-waist circumference; TyG-WHtR: triglyceride glucose- waist-to-height ratio; ALT: alanine aminotransferase; AST: aspartate aminotransferase; GGT: gamma-glutamyl transferase; HDL-C: high-density lipoprotein cholesterol; TC: total cholesterol; TG: triglyceride; TG/HDL-C: triglyceride to high-density lipoprotein cholesterol ratio; HbA1c: hemoglobin A1c; FPG: fasting plasma glucose; SBP: systolic blood pressure; DBP: Diastolic blood pressure; HIS: hepatic steatosis index; VAI: visceral adiposity index; LAP: lipid accumulation product; ABSI: body-shape index; BRI: body roundness index; COI: conicity index.